Lifeblood Biological Services, LLC, (LBS) provides critical support through all phases of medical research by providing human cells, other biological materials, and laboratory supplies to assist the development of biological therapeutics and diagnostic products by private and public companies, as well as academic institutions.

LBS is a wholly owned, not-for-profit subsidiary of the Mid-South Regional Blood Center (dba Lifeblood®).

LBS was created in 1999 as a department within the Mid-South Regional Blood Center (dba Lifeblood®). Lifeblood is an FDA-licensed, not-for-profit, regional blood center headquartered in Memphis, Tennessee. Its core business is the provision of blood components and related services to health care facilities in a 15-county area surrounding Memphis. LBS was created to focus on opportunities to provide human-derived biological products and related services for new markets. LBS adopted the current Good Manufacturing Practices (cGMP)-compliant framework that exists within Lifeblood and applied the organization’s skill, knowledge, and resources to non-core customers, i.e., customers needing non-transfusible blood products and related services for purposes other than direct patient care.

Lifeblood Biological Services, LLC, became a wholly owned, not-for-profit subsidiary of Lifeblood in 2005.

LBS is a proven, reliable supplier to some of the most recognized firms in cell-therapy research.

We are uniquely positioned to support the collection of blood components for use in biomedical research both in the U.S. and around the world. Advantages include:

• Almost a decade of experience in recruiting, collecting, and delivering human-derived biological materials from non-traditional blood donors
  
  
• Ability to draw on the 40+ years of experience of our parent blood center in blood donor selection and management, as well as the collection, processing, storage, and distribution of blood products
  
  
• A keen understanding of the requirement for early stage companies to maximize the return from every dollar spent on research to allow advancement to additional funding rounds
  
  
• Ability to provide products and services to support research from pre-clinical stage through all phases of clinical trials
  
  
• Expertise in developing and submitting research protocols to IRBs on behalf of customers, gaining approval for such studies, and completing them in a timely and cost-effective manner
  
  
• Expertise in performing customized boutique collections of various biological materials to meet the demanding specifications of customers
  
  
• Extensive training and competence in matters regarding the safety and protection of donors